Latest filing published 30 Mar 2023 for Miromatrix Medical Inc., €9,448.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
John Joseph Barry, listed as senior executive, appears in our data through filings on Miromatrix Medical Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 October 2021 to 10 March 2023, the count stands at 5 filings.
The open-market record is one-sided, with 1 purchase worth €9,448 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants. So far in 2023, the count stands at 1 purchase and no sales.
On 30 March 2023 came the latest disclosure, an open-market purchase for €9,448 in Miromatrix Medical Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations